Project Grant HT94252410259
Award Date
4/1/24
Completion Date
3/31/28
Dollars Obligated
$1M
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02114, USA
Similar Awards
The Department of the Army Medical Command awarded The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), a $992,302.00 project grant under the Military Medical Research and Development (CFDA 12.420) program. The grant supports advanced biomedical research initiatives focused on transforming healthcare for military service members and the broader public. Specifically, the award funds research to target MHC II ubiquitination in order to induce immune...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), was awarded a $577,094 Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research aimed at "Redirecting Viral Immunity to Eradicate Low Tumor Mutation Burden Lung Cancers." The award period runs from Aug 31, 2023 to Aug 29, 2025. As a leading academic medical center and research institution, MGH utilizes its...
The Department of the Army Medical Command has awarded a $1,644,309 Project Grant (CFDA 12.420 - Military Medical Research and Development) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on "Functional Molecular Networks Modifying HIF2A Activity in VHL Tumors." The award period runs from February 1, 2025 to January 31, 2028. MGH, a renowned nonprofit academic medical center, will leverage its extensive research...
The federal Project Grant award, valued at $888,632.00 and awarded on April 1, 2025, was provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program. The grant supports research at The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to investigate the role of maternal autoantibodies in inducing behavioral abnormalities in offspring following maternal TLR7 activation. This advanced biomedical research...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,234,505.00 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to conduct research on cotargeting the tumor microenvironment to improve antibody-drug conjugate therapy for refractory breast cancers. The award period runs from March 1, 2025 to February 29, 2028. As a renowned academic medical center and major...
The General Hospital Corporation, doing business as Massachusetts General Hospital, received a $1,255,920 Project Grant award from the Department of the Army Medical Command on February 1, 2022, with a completion date of January 31, 2026. The grant was awarded under the Military Medical Research and Development program to support innovative biomedical research that transforms military and public health care. Specifically, the funding will support research to develop synergistic prostate-specific...
The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), received a $1,865,846 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) on July 1, 2024. The funding will support the project "TARGETING NEUROIMMUNE AND EPITHELIAL SIGNALING FOR ECZEMA TREATMENT" through June 30, 2028. MGH, a leading academic medical center and research institution, will conduct biomedical research,...
This federal Project Grant award from the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program provides $1,498,368.00 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to elucidate molecular mechanisms of tumor-immune dynamics and evolution in response to radiation for optimizing treatment of high- and very high-risk prostate cancer. The award period runs from August 1, 2024, to July 31, 2027. As a renowned...
The General Hospital Corporation, doing business as Massachusetts General Hospital, was awarded a $302,801 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development federal grant program (CFDA 12.420). The grant will support research from September 1, 2022 to August 31, 2025 to advance a tissue oxygenation measurement device and evaluate galectin-3 as novel noninvasive prognostic biomarkers for monitoring vascularized composite...
This Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) provides $730,033 to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), for research to develop therapies targeting AMH signaling within the ovarian cancer tumor microenvironment. The award has a performance period from April 15, 2024 to April 14, 2027. As part of its extensive biomedical research portfolio,...